<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37328761</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1465-993X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Respiratory research</Title><ISOAbbreviation>Respir Res</ISOAbbreviation></Journal><ArticleTitle>Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder.</ArticleTitle><Pagination><StartPage>158</StartPage><MedlinePgn>158</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">158</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-023-02458-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel coronavirus that caused an ongoing pandemic of a pathology termed Coronavirus Disease 19 (COVID-19). Several studies reported that both COVID-19 and RTEL1 variants are associated with shorter telomere length, but a direct association between the two is not generally acknowledged. Here we demonstrate that up to 8.6% of severe COVID-19 patients bear RTEL1 ultra-rare variants, and show how this subgroup can be recognized.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort of 2246 SARS-CoV-2-positive subjects, collected within the GEN-COVID Multicenter study, was used in this work. Whole exome sequencing analysis was performed using the NovaSeq6000 System, and machine learning methods were used for candidate gene selection of severity. A nested study, comparing severely affected patients bearing or not variants in the selected gene, was used for the characterisation of specific clinical features connected to variants in both acute and post-acute phases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our GEN-COVID cohort revealed a total of 151 patients carrying at least one RTEL1 ultra-rare variant, which was selected as a specific acute severity feature. From a clinical point of view, these patients showed higher liver function indices, as well as increased CRP and inflammatory markers, such as IL-6. Moreover, compared to control subjects, they present autoimmune disorders more frequently. Finally, their decreased diffusion lung capacity for carbon monoxide after six months of COVID-19 suggests that RTEL1 variants can contribute to the development of SARS-CoV-2-elicited lung fibrosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">RTEL1 ultra-rare variants can be considered as a predictive marker of COVID-19 severity, as well as a marker of pathological evolution in pulmonary fibrosis in the post-COVID phase. This notion can be used for a rapid screening in hospitalized infected people, for vaccine prioritization, and appropriate follow-up assessment for subjects at risk. Trial Registration NCT04549831 ( www.</AbstractText><AbstractText Label="CLINICALTRIAL" NlmCategory="BACKGROUND">org ).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bergantini</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Medical Sciences, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Baldassarri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Alessandro</LastName><ForeName>Miriana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Medical Sciences, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunelli</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Medical Sciences, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zguro</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degl'Innocenti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>GEN-COVID Multicenter study</CollectiveName></Author><Author ValidYN="Y"><LastName>Fallerini</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargagli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Medical Sciences, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy. bargagli2@unisi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renieri</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy. alessandra.renieri@unisi.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100, Siena, Italy. alessandra.renieri@unisi.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetica Medica, Azienda Ospedaliero-Universitaria Senese, 53100, Siena, Italy. alessandra.renieri@unisi.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04549831</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>Bando Ricerca COVID-19 Toscana</GrantID><Agency>Azienda Ospedaliero-Universitaria Senese</Agency><Country/></Grant><Grant><GrantID>N B/2020/0119 "Identificazione delle basi genetiche determinanti la variabilit&#xe0; clinica della risposta a COVID-19 nella popolazione italiana</GrantID><Agency>Intesa San Paolo 2020 charity fund</Agency><Country/></Grant><Grant><GrantID>Bando FISR 2020 "Editing dell'RNA contro il SARS-CoV-2: hackerare il virus per identificare bersagli molecolari e attenuare l'infezione - HACKTHECOV"</GrantID><Agency>Italian Ministry of University and Research</Agency><Country/></Grant><Grant><GrantID>"PAT-COVID: Host genetics and pathogenetic mechanisms of COVID-19" (ID n. 2020-2016_RIC_3)</GrantID><Agency>Istituto Buddista Italiano Soka Gakkai</Agency><Country/></Grant><Grant><GrantID>International consortium for integrative genomics prediction (INTERVENE) Grant Agreement No. 101016775</GrantID><Agency>EU project H2020-SC1-FA-DTS-2018-2020</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Res</MedlineTA><NlmUniqueID>101090633</NlmUniqueID><ISSNLinking>1465-9921</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C532890">RTEL1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="Y">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="Y">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pulmonary fibrosis</Keyword><Keyword MajorTopicYN="N">RTEL1</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Mari</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daga</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meloni</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruttini</LastName><ForeName>Mirella</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croci</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lista</LastName><ForeName>Mirjam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maffeo</LastName><ForeName>Debora</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasquinelli</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serio</LastName><ForeName>Viola Bianca</ForeName><Initials>VB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antolini</LastName><ForeName>Enrica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basso</LastName><ForeName>Simona Letizia</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minetto</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tita</LastName><ForeName>Rossella</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mencarelli</LastName><ForeName>Maria Antonietta</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Caterina Lo</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ariani</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montagnani</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tumbarello</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rancan</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabbiani</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cameli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennett</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anedda</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcantonio</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scolletta</LastName><ForeName>Sabino</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franchi</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzei</LastName><ForeName>Maria Antonietta</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerrini</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conticini</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cantarini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frediani</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tacconi</LastName><ForeName>Danilo</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raffaelli</LastName><ForeName>Chiara Spertilli</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Emiliozzi</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donati</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scala</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guidelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spargi</LastName><ForeName>Genni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corridi</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nencioni</LastName><ForeName>Cesira</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croci</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caldarelli</LastName><ForeName>Gian Piero</ForeName><Initials>GP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romani</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piacentini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bandini</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desanctis</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canaccini</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verzuri</LastName><ForeName>Agnese</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anemoli</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pisani</LastName><ForeName>Manola</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ognibene</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorubbio</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pancrazzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaghi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monforte</LastName><ForeName>Antonella D 'Arminio</ForeName><Initials>AD'</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miraglia</LastName><ForeName>Federica Gaia</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mondelli</LastName><ForeName>Mario U</ForeName><Initials>MU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruno</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vecchia</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maffezzoni</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Busani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venturelli</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossarizza</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antinori</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vergori</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rusconi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siano</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabrieli</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riva</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francisci</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiaroli</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pallotto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parisi</LastName><ForeName>Saverio Giuseppe</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Basso</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panese</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baratti</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scotton</LastName><ForeName>Pier Giorgio</ForeName><Initials>PG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andretta</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giobbia</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scaggiante</LastName><ForeName>Renzo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gatti</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quiros-Roldan</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antoni</LastName><ForeName>Melania Degli</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zanella</LastName><ForeName>Isabella</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monica</LastName><ForeName>Matteo Della</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piscopo</LastName><ForeName>Carmelo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capasso</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russo</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andolfo</LastName><ForeName>Immacolata</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iolascon</LastName><ForeName>Achille</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carella</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castori</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merla</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Squeo</LastName><ForeName>Gabriella Maria</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aucella</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raggi</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perna</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Biagio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanguinetti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masucci</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guarnaccia</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valente</LastName><ForeName>Serafina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Florio</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mandal&#xe0;</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giorli</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salerni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zucchi</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parravicini</LastName><ForeName>Pierpaolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menatti</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trotta</LastName><ForeName>Tullio</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giannattasio</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coiro</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lena</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacerenza</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mussini</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tavecchia</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crotti</LastName><ForeName>Lia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parati</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Men&#xe8;</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanarico</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gori</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raimondi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stella</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biscarini</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bachetti</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Rovere</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bussotti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ludovisi</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capitani</LastName><ForeName>Katia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dei</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravaglia</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giliberti</LastName><ForeName>Annarita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gori</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artuso</LastName><ForeName>Rosangela</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andreucci</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pagliazzi</LastName><ForeName>Angelica</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentini</LastName><ForeName>Erika</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrella</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergomi</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catena</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luchi</LastName><ForeName>Sauro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morelli</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrocelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iacopini</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Modica</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baroni</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Micheli</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falcone</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Urso</LastName><ForeName>Donato</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiseo</LastName><ForeName>Giusy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matucci</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grassi</LastName><ForeName>Davide</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferri</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marinangeli</LastName><ForeName>Franco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brancati</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincenti</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borgo</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenzi</LastName><ForeName>Mirco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Pietro</LastName><ForeName>Massimo Antonio</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vichi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romanin</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Attala</LastName><ForeName>Letizia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costa</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabbuti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellucci</LastName><ForeName>Alessio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colaneri</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casprini</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pomara</LastName><ForeName>Cristoforo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esposito</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leoncini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cirianni</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galasso</LastName><ForeName>Lucrezia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellini</LastName><ForeName>Marco Antonio</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabbi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Picchiotti</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furini</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>16</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328761</ArticleId><ArticleId IdType="pmc">PMC10276396</ArticleId><ArticleId IdType="doi">10.1186/s12931-023-02458-7</ArticleId><ArticleId IdType="pii">10.1186/s12931-023-02458-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Croci S, Venneri MA, Mantovani S, Fallerini C, Benetti E, Picchiotti N, et al. The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. Autophagy. 2022;18:1662&#x2013;1672. doi: 10.1080/15548627.2021.1995152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1995152</ArticleId><ArticleId IdType="pmc">PMC9298458</ArticleId><ArticleId IdType="pubmed">34964709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecevic M, Kotur N, Ristivojevic B, Gasic V, Skodric-Trifunovic V, Stjepanovic M, et al. Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population. Front Genetics [Internet]. 2022 doi: 10.3389/fgene.2022.911010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.911010</ArticleId><ArticleId IdType="pmc">PMC9329799</ArticleId><ArticleId IdType="pubmed">35910207</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scial&#xf2; F, et al. Prognostic role of neutrophil to lymphocyte ratio in COVID-19 patients: still valid in patients that had started therapy? Front Public Health. 2021 doi: 10.3389/fpubh.2021.664108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.664108</ArticleId><ArticleId IdType="pmc">PMC8239130</ArticleId><ArticleId IdType="pubmed">34211953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Vazquez R, Gu&#xed;o-Carri&#xf3;n A, Zapatero-Gaviria A, Mart&#xed;nez P, Blasco MA. Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY) 2021;13:1&#x2013;15. doi: 10.18632/aging.202463.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202463</ArticleId><ArticleId IdType="pmc">PMC7835063</ArticleId><ArticleId IdType="pubmed">33428591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Barbi V, Gottardi Zamperla M, Atlante S, Forleo L, Nesta M, et al. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci [Internet]. 2021;22:6151. doi: 10.3390/ijms22116151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:25&#x2013;34. doi: 10.1016/S0092-8674(01)80006-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)80006-4</ArticleId><ArticleId IdType="pubmed">9335332</ArticleId></ArticleIdList></Reference><Reference><Citation>Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet [Internet]. 2012;13:693&#x2013;704. doi: 10.1038/nrg3246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3246</ArticleId><ArticleId IdType="pmc">PMC3548426</ArticleId><ArticleId IdType="pubmed">22965356</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart BD, Choi J, Zaidi S, Xing C, Holohan B, Chen R, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet [Internet]. 2015;47:512&#x2013;517. doi: 10.1038/ng.3278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3278</ArticleId><ArticleId IdType="pmc">PMC4414891</ArticleId><ArticleId IdType="pubmed">25848748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannengiesser C, Borie R, M&#xe9;nard C, R&#xe9;ocreux M, Nitschk&#xe9; P, Gazal S, et al. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. Eur Respir J. 2015;46:474&#x2013;485. doi: 10.1183/09031936.00040115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00040115</ArticleId><ArticleId IdType="pubmed">26022962</ArticleId></ArticleIdList></Reference><Reference><Citation>Juge P-A, Borie R, Kannengiesser C, Gazal S, Revy P, Wemeau-Stervinou L, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. 2017;49:1602314. doi: 10.1183/13993003.02314-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02314-2016</ArticleId><ArticleId IdType="pubmed">28495692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogan JD, Kropski JA, Zhao M, Mitchell DB, Rives L, Markin C, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med. 2015;191:646&#x2013;655. doi: 10.1164/rccm.201408-1510OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201408-1510OC</ArticleId><ArticleId IdType="pmc">PMC4384777</ArticleId><ArticleId IdType="pubmed">25607374</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Carmona S, Falf&#xe1;n-Valencia R, Ver&#xf3;nica-Aguilar A, Buend&#xed;a-Rold&#xe1;n I, Ch&#xe1;vez-Gal&#xe1;n L, Hern&#xe1;ndez-Zenteno RJ, et al. COVID-19 survivor patients carrying the Rs35705950 risk allele in MUC5B have higher plasma levels of mucin 5B. Curr Issues Mol Biol. 2022;44:3283&#x2013;3290. doi: 10.3390/cimb44080226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44080226</ArticleId><ArticleId IdType="pmc">PMC9329856</ArticleId><ArticleId IdType="pubmed">35892712</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L, Mainardi A, d&#x2019;Alessandro M, Cameli P, Bennett D, Bargagli E, et al. Common molecular pathways between post-COVID19 syndrome and lung fibrosis: a scoping review. Front Pharmacol. 2022;13:748931. doi: 10.3389/fphar.2022.748931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.748931</ArticleId><ArticleId IdType="pmc">PMC8931519</ArticleId><ArticleId IdType="pubmed">35308222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2022;141:147&#x2013;173. doi: 10.1007/s00439-021-02397-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-021-02397-7</ArticleId><ArticleId IdType="pmc">PMC8661833</ArticleId><ArticleId IdType="pubmed">34889978</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang B-S, Guo J-F, Li J-C. Telomere length and COVID-19 outcomes: a two-sample bidirectional Mendelian randomization study. Front Genet. 2022;13:805903. doi: 10.3389/fgene.2022.805903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.805903</ArticleId><ArticleId IdType="pmc">PMC9168682</ArticleId><ArticleId IdType="pubmed">35677559</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor J, Jordan T, Lamkin E, Ikeh K, March A, Frere J, et al. SARS-CoV-2 hijacks host cell genome instability pathways. Res Sq. 2022;rs.3.rs-1556634.</Citation></Reference><Reference><Citation>COVID-19 Therapeutic Trial Synopsis [Internet]. [cited 2023 Jan 14]. Available from: https://www.who.int/publications-detail-redirect/covid-19-therapeutic-trial-synopsis</Citation></Reference><Reference><Citation>Daga S, Fallerini C, Baldassarri M, Fava F, Valentino F, Doddato G, et al. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research. Eur J Hum Genet. 2021;29:745&#x2013;759. doi: 10.1038/s41431-020-00793-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-020-00793-7</ArticleId><ArticleId IdType="pmc">PMC7811682</ArticleId><ArticleId IdType="pubmed">33456056</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiotti N, Benetti E, Fallerini C, Daga S, Baldassarri M, Fava F, et al. Post-Mendelian genetic model in COVID-19. Cardiol Cardiovasc Med. 2021;5(6):673&#x2013;769. doi: 10.1101/2021.01.27.21250593v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250593v1</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608:E1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352569</ArticleId><ArticleId IdType="pubmed">35922517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarraso J, Safont B, Carbonell-Asins JA, Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, et al. Lung function and radiological findings 1 year after COVID-19: a prospective follow-up. Respir Res. 2022;23:242. doi: 10.1186/s12931-022-02166-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02166-8</ArticleId><ArticleId IdType="pmc">PMC9466319</ArticleId><ArticleId IdType="pubmed">36096801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama Amin BJ, Kakamad FH, Ahmed GS, Ahmed SF, Abdulla BA, Mohammed SH, et al. Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann Med Surg (Lond) 2022;77:103590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983072</ArticleId><ArticleId IdType="pubmed">35411216</ArticleId></ArticleIdList></Reference><Reference><Citation>van Moorsel CHM, van der Vis JJ, Duckworth A, Scotton CJ, Benschop C, Ellinghaus D, et al. The MUC5B promoter polymorphism associates with severe COVID-19 in the European population. Front Med [Internet]. 2021 doi: 10.3389/fmed.2021.668024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.668024</ArticleId><ArticleId IdType="pmc">PMC8650310</ArticleId><ArticleId IdType="pubmed">34888316</ArticleId></ArticleIdList></Reference><Reference><Citation>Retuerto M, Lled&#xf3; A, Fernandez-Varas B, Guerrero-L&#xf3;pez R, Usategui A, Lalueza A, et al. Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities. Immunity Ageing [Internet]. 2022;19:38. doi: 10.1186/s12979-022-00294-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-022-00294-9</ArticleId><ArticleId IdType="pmc">PMC9394033</ArticleId><ArticleId IdType="pubmed">35996190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng F, Carroll L, Joglekar MV, Januszewski AS, Wong KK, Hardikar AA, et al. Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021;9:117&#x2013;126. doi: 10.1016/S2213-8587(20)30365-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30365-X</ArticleId><ArticleId IdType="pubmed">33248477</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#x2019;Kacher R, Jaillet M, Colicchio B, Vasarmidi E, Mailleux A, Dieterlen A, et al. Lung fibroblasts from idiopathic pulmonary fibrosis patients harbor short and unstable telomeres leading to chromosomal instability. Biomedicines. 2022;10:310. doi: 10.3390/biomedicines10020310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020310</ArticleId><ArticleId IdType="pmc">PMC8869717</ArticleId><ArticleId IdType="pubmed">35203522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kropski JA, Loyd JE. Telomeres revisited: RTEL1 variants in pulmonary fibrosis. Eur Respir J. 2015;46:312&#x2013;314. doi: 10.1183/13993003.00710-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00710-2015</ArticleId><ArticleId IdType="pmc">PMC5084689</ArticleId><ArticleId IdType="pubmed">26232478</ArticleId></ArticleIdList></Reference><Reference><Citation>Borie R, Bouvry D, Cottin V, Gauvain C, Cazes A, Debray M-P, et al. Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes. Eur Respir J. 2019;53:1800508. doi: 10.1183/13993003.00508-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00508-2018</ArticleId><ArticleId IdType="pubmed">30523160</ArticleId></ArticleIdList></Reference><Reference><Citation>Mank VMF, Mank J, Ogle J, Roberts J. Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia. BMJ Case Reports CP [Internet]. 2021;14:e242596. doi: 10.1136/bcr-2021-242596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-242596</ArticleId><ArticleId IdType="pmc">PMC8117979</ArticleId><ArticleId IdType="pubmed">33980567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman TT, Sagi M, Shafir Y, Sheena L, Cohen E, Goldberg E, et al. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients. Br J Clin Pharmacol [Internet]. 2021;87:2902&#x2013;2906. doi: 10.1111/bcp.14703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.14703</ArticleId><ArticleId IdType="pubmed">33332642</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/nejmoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Pereira P, Iturrate I, de La C&#xe1;mara R, Carde&#xf1;oso L, Alegre A, Aguado B. Can COVID-19 cause severe neutropenia? Clin Case Rep. 2020;8:3349&#x2013;3351. doi: 10.1002/ccr3.3369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3369</ArticleId><ArticleId IdType="pmc">PMC7752313</ArticleId><ArticleId IdType="pubmed">33363932</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha M, Sharma A, Soubani A. Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19. Respir Med Case Rep. 2020;31:101231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515585</ArticleId><ArticleId IdType="pubmed">32999856</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Ratre BK, Sirohiya P, Bhatnagar S. Self-limiting severe neutropenia in a patient with COVID-19. BMJ Case Rep. 2021;14:e247057. doi: 10.1136/bcr-2021-247057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-247057</ArticleId><ArticleId IdType="pmc">PMC8634211</ArticleId><ArticleId IdType="pubmed">34848430</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020;225:31&#x2013;32. doi: 10.1016/j.imlet.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7305732</ArticleId><ArticleId IdType="pubmed">32569607</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathi A, Padukudru S, Arunachal S, Basavaraj CK, Krishna MT, Ganguly K, et al. The role of neutrophil-to-lymphocyte ratio in risk stratification and prognostication of COVID-19: a systematic review and meta-analysis. Vaccines (Basel) 2022;10:1233. doi: 10.3390/vaccines10081233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081233</ArticleId><ArticleId IdType="pmc">PMC9415708</ArticleId><ArticleId IdType="pubmed">36016121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rello AP, Mart&#xed;nez AM, Iturbe CV, Escolano-Pueyo A, Bayo EH, Lafarga IA. Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital. Eur J Hosp Pharm [Internet]. British Medical Journal Publishing Group; 2022 [cited 2023 Jan 14]; Available from: https://ejhp.bmj.com/content/early/2022/09/23/ejhpharm-2022-003366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11042469</ArticleId><ArticleId IdType="pubmed">36150845</ArticleId></ArticleIdList></Reference><Reference><Citation>Besutti G, Pellegrini M, Ottone M, Bonelli E, Monelli F, Far&#xec; R, et al. Modifications of chest CT body composition parameters at three and six months after severe COVID-19 pneumonia: a retrospective cohort study. Nutrients. 2022;14:3764. doi: 10.3390/nu14183764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14183764</ArticleId><ArticleId IdType="pmc">PMC9501258</ArticleId><ArticleId IdType="pubmed">36145141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A, Mangoni AA. A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality. Expert Rev Clin Immunol. 2022;18:1187&#x2013;1202. doi: 10.1080/1744666X.2022.2120472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2022.2120472</ArticleId><ArticleId IdType="pubmed">36047369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z-Z, Fan L-L, Wang C-Y, Luo H, Liu L. Novel heterozygous mutation of RTEL1 in interstitial pneumonia with autoimmune feature. QJM. 2022;115:253&#x2013;255. doi: 10.1093/qjmed/hcab315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab315</ArticleId><ArticleId IdType="pubmed">34894270</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010;12:753&#x2013;764. doi: 10.1097/GIM.0b013e3181f415b5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GIM.0b013e3181f415b5</ArticleId><ArticleId IdType="pmc">PMC3825100</ArticleId><ArticleId IdType="pubmed">21189492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman TW, van der Vis JJ, Biesma DH, Grutters JC, van Moorsel CHM. Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival. Respirology. 2022;27:959&#x2013;965. doi: 10.1111/resp.14264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14264</ArticleId><ArticleId IdType="pubmed">35419815</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Rosso A, Cecchini P, Torrigiani A, Lo Forte A, Carrai P, et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome. Infection. 2022;50:513&#x2013;517. doi: 10.1007/s15010-022-01755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01755-5</ArticleId><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="pubmed">35061232</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>